midazolam has been researched along with Lung Diseases, Interstitial in 1 studies
Midazolam: A short-acting hypnotic-sedative drug with anxiolytic and amnestic properties. It is used in dentistry, cardiac surgery, endoscopic procedures, as preanesthetic medication, and as an adjunct to local anesthesia. The short duration and cardiorespiratory stability makes it useful in poor-risk, elderly, and cardiac patients. It is water-soluble at pH less than 4 and lipid-soluble at physiological pH.
midazolam : An imidazobenzodiazepine that is 4H-imidazo[1,5-a][1,4]benzodiazepine which is substituted by a methyl, 2-fluorophenyl and chloro groups at positions 1, 6 and 8, respectively.
Lung Diseases, Interstitial: A diverse group of lung diseases that affect the lung parenchyma. They are characterized by an initial inflammation of PULMONARY ALVEOLI that extends to the interstitium and beyond leading to diffuse PULMONARY FIBROSIS. Interstitial lung diseases are classified by their etiology (known or unknown causes), and radiological-pathological features.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 1 (100.00) | 2.80 |
| Authors | Studies |
|---|---|
| Okabayashi, H | 1 |
| Kitamura, H | 1 |
| Ikeda, S | 1 |
| Sekine, A | 1 |
| Oda, T | 1 |
| Baba, T | 1 |
| Hagiwara, E | 1 |
| Sakagami, T | 1 |
| Ogura, T | 1 |
1 other study available for midazolam and Lung Diseases, Interstitial
| Article | Year |
|---|---|
Impact of interstitial pneumonia complications on palliative medication for terminal lung cancer: A single-center retrospective study.
Topics: Humans; Hypnotics and Sedatives; Lung Diseases, Interstitial; Lung Neoplasms; Midazolam; Palliative | 2021 |